Global Vaccines Administered Orally Market Growth 2022-2028

Global Vaccines Administered Orally Market Growth 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vaccines Administered Orally Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Vaccines Administered Orally by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Vaccines Administered Orally by Country/Region, 2017, 2022 & 2028
2.2 Vaccines Administered Orally Segment by Type
2.2.1 Human
2.2.2 Animal
2.3 Vaccines Administered Orally Sales by Type
2.3.1 Global Vaccines Administered Orally Sales Market Share by Type (2017-2022)
2.3.2 Global Vaccines Administered Orally Revenue and Market Share by Type (2017-2022)
2.3.3 Global Vaccines Administered Orally Sale Price by Type (2017-2022)
2.4 Vaccines Administered Orally Segment by Application
2.4.1 Public
2.4.2 Private
2.5 Vaccines Administered Orally Sales by Application
2.5.1 Global Vaccines Administered Orally Sale Market Share by Application (2017-2022)
2.5.2 Global Vaccines Administered Orally Revenue and Market Share by Application (2017-2022)
2.5.3 Global Vaccines Administered Orally Sale Price by Application (2017-2022)
3 Global Vaccines Administered Orally by Company
3.1 Global Vaccines Administered Orally Breakdown Data by Company
3.1.1 Global Vaccines Administered Orally Annual Sales by Company (2020-2022)
3.1.2 Global Vaccines Administered Orally Sales Market Share by Company (2020-2022)
3.2 Global Vaccines Administered Orally Annual Revenue by Company (2020-2022)
3.2.1 Global Vaccines Administered Orally Revenue by Company (2020-2022)
3.2.2 Global Vaccines Administered Orally Revenue Market Share by Company (2020-2022)
3.3 Global Vaccines Administered Orally Sale Price by Company
3.4 Key Manufacturers Vaccines Administered Orally Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccines Administered Orally Product Location Distribution
3.4.2 Players Vaccines Administered Orally Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Vaccines Administered Orally by Geographic Region
4.1 World Historic Vaccines Administered Orally Market Size by Geographic Region (2017-2022)
4.1.1 Global Vaccines Administered Orally Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Vaccines Administered Orally Annual Revenue by Geographic Region
4.2 World Historic Vaccines Administered Orally Market Size by Country/Region (2017-2022)
4.2.1 Global Vaccines Administered Orally Annual Sales by Country/Region (2017-2022)
4.2.2 Global Vaccines Administered Orally Annual Revenue by Country/Region
4.3 Americas Vaccines Administered Orally Sales Growth
4.4 APAC Vaccines Administered Orally Sales Growth
4.5 Europe Vaccines Administered Orally Sales Growth
4.6 Middle East & Africa Vaccines Administered Orally Sales Growth
5 Americas
5.1 Americas Vaccines Administered Orally Sales by Country
5.1.1 Americas Vaccines Administered Orally Sales by Country (2017-2022)
5.1.2 Americas Vaccines Administered Orally Revenue by Country (2017-2022)
5.2 Americas Vaccines Administered Orally Sales by Type
5.3 Americas Vaccines Administered Orally Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccines Administered Orally Sales by Region
6.1.1 APAC Vaccines Administered Orally Sales by Region (2017-2022)
6.1.2 APAC Vaccines Administered Orally Revenue by Region (2017-2022)
6.2 APAC Vaccines Administered Orally Sales by Type
6.3 APAC Vaccines Administered Orally Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Vaccines Administered Orally by Country
7.1.1 Europe Vaccines Administered Orally Sales by Country (2017-2022)
7.1.2 Europe Vaccines Administered Orally Revenue by Country (2017-2022)
7.2 Europe Vaccines Administered Orally Sales by Type
7.3 Europe Vaccines Administered Orally Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Vaccines Administered Orally by Country
8.1.1 Middle East & Africa Vaccines Administered Orally Sales by Country (2017-2022)
8.1.2 Middle East & Africa Vaccines Administered Orally Revenue by Country (2017-2022)
8.2 Middle East & Africa Vaccines Administered Orally Sales by Type
8.3 Middle East & Africa Vaccines Administered Orally Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaccines Administered Orally
10.3 Manufacturing Process Analysis of Vaccines Administered Orally
10.4 Industry Chain Structure of Vaccines Administered Orally
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaccines Administered Orally Distributors
11.3 Vaccines Administered Orally Customer
12 World Forecast Review for Vaccines Administered Orally by Geographic Region
12.1 Global Vaccines Administered Orally Market Size Forecast by Region
12.1.1 Global Vaccines Administered Orally Forecast by Region (2023-2028)
12.1.2 Global Vaccines Administered Orally Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vaccines Administered Orally Forecast by Type
12.7 Global Vaccines Administered Orally Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Vaccines Administered Orally Product Offered
13.1.3 Merck Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Vaccines Administered Orally Product Offered
13.2.3 GSK Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Vaccines Administered Orally Product Offered
13.3.3 Sanofi Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Lanzhou Institute
13.4.1 Lanzhou Institute Company Information
13.4.2 Lanzhou Institute Vaccines Administered Orally Product Offered
13.4.3 Lanzhou Institute Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Lanzhou Institute Main Business Overview
13.4.5 Lanzhou Institute Latest Developments
13.5 Serum Institute
13.5.1 Serum Institute Company Information
13.5.2 Serum Institute Vaccines Administered Orally Product Offered
13.5.3 Serum Institute Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Serum Institute Main Business Overview
13.5.5 Serum Institute Latest Developments
13.6 Valneva
13.6.1 Valneva Company Information
13.6.2 Valneva Vaccines Administered Orally Product Offered
13.6.3 Valneva Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Valneva Main Business Overview
13.6.5 Valneva Latest Developments
13.7 Shanghai United Cell
13.7.1 Shanghai United Cell Company Information
13.7.2 Shanghai United Cell Vaccines Administered Orally Product Offered
13.7.3 Shanghai United Cell Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Shanghai United Cell Main Business Overview
13.7.5 Shanghai United Cell Latest Developments
13.8 Bibcol
13.8.1 Bibcol Company Information
13.8.2 Bibcol Vaccines Administered Orally Product Offered
13.8.3 Bibcol Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bibcol Main Business Overview
13.8.5 Bibcol Latest Developments
13.9 PaxVax
13.9.1 PaxVax Company Information
13.9.2 PaxVax Vaccines Administered Orally Product Offered
13.9.3 PaxVax Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 PaxVax Main Business Overview
13.9.5 PaxVax Latest Developments
13.10 Vabiotech
13.10.1 Vabiotech Company Information
13.10.2 Vabiotech Vaccines Administered Orally Product Offered
13.10.3 Vabiotech Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Vabiotech Main Business Overview
13.10.5 Vabiotech Latest Developments
13.11 Tiantan Biological
13.11.1 Tiantan Biological Company Information
13.11.2 Tiantan Biological Vaccines Administered Orally Product Offered
13.11.3 Tiantan Biological Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Tiantan Biological Main Business Overview
13.11.5 Tiantan Biological Latest Developments
13.12 EuBiologics
13.12.1 EuBiologics Company Information
13.12.2 EuBiologics Vaccines Administered Orally Product Offered
13.12.3 EuBiologics Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 EuBiologics Main Business Overview
13.12.5 EuBiologics Latest Developments
13.13 Panacea Biotec Ltd
13.13.1 Panacea Biotec Ltd Company Information
13.13.2 Panacea Biotec Ltd Vaccines Administered Orally Product Offered
13.13.3 Panacea Biotec Ltd Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Panacea Biotec Ltd Main Business Overview
13.13.5 Panacea Biotec Ltd Latest Developments
13.14 Bio-Med
13.14.1 Bio-Med Company Information
13.14.2 Bio-Med Vaccines Administered Orally Product Offered
13.14.3 Bio-Med Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Bio-Med Main Business Overview
13.14.5 Bio-Med Latest Developments
13.15 Halfkin Bio-Pharmaceuticals
13.15.1 Halfkin Bio-Pharmaceuticals Company Information
13.15.2 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product Offered
13.15.3 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Halfkin Bio-Pharmaceuticals Main Business Overview
13.15.5 Halfkin Bio-Pharmaceuticals Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Vaccines Administered Orally Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Vaccines Administered Orally Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Human
Table 4. Major Players of Animal
Table 5. Global Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)
Table 6. Global Vaccines Administered Orally Sales Market Share by Type (2017-2022)
Table 7. Global Vaccines Administered Orally Revenue by Type (2017-2022) & ($ million)
Table 8. Global Vaccines Administered Orally Revenue Market Share by Type (2017-2022)
Table 9. Global Vaccines Administered Orally Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)
Table 11. Global Vaccines Administered Orally Sales Market Share by Application (2017-2022)
Table 12. Global Vaccines Administered Orally Revenue by Application (2017-2022)
Table 13. Global Vaccines Administered Orally Revenue Market Share by Application (2017-2022)
Table 14. Global Vaccines Administered Orally Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Vaccines Administered Orally Sales by Company (2020-2022) & (K Units)
Table 16. Global Vaccines Administered Orally Sales Market Share by Company (2020-2022)
Table 17. Global Vaccines Administered Orally Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Vaccines Administered Orally Revenue Market Share by Company (2020-2022)
Table 19. Global Vaccines Administered Orally Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Vaccines Administered Orally Producing Area Distribution and Sales Area
Table 21. Players Vaccines Administered Orally Products Offered
Table 22. Vaccines Administered Orally Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Vaccines Administered Orally Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Vaccines Administered Orally Sales Market Share Geographic Region (2017-2022)
Table 27. Global Vaccines Administered Orally Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Vaccines Administered Orally Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Vaccines Administered Orally Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Vaccines Administered Orally Sales Market Share by Country/Region (2017-2022)
Table 31. Global Vaccines Administered Orally Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Vaccines Administered Orally Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)
Table 34. Americas Vaccines Administered Orally Sales Market Share by Country (2017-2022)
Table 35. Americas Vaccines Administered Orally Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Vaccines Administered Orally Revenue Market Share by Country (2017-2022)
Table 37. Americas Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)
Table 38. Americas Vaccines Administered Orally Sales Market Share by Type (2017-2022)
Table 39. Americas Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)
Table 40. Americas Vaccines Administered Orally Sales Market Share by Application (2017-2022)
Table 41. APAC Vaccines Administered Orally Sales by Region (2017-2022) & (K Units)
Table 42. APAC Vaccines Administered Orally Sales Market Share by Region (2017-2022)
Table 43. APAC Vaccines Administered Orally Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Vaccines Administered Orally Revenue Market Share by Region (2017-2022)
Table 45. APAC Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)
Table 46. APAC Vaccines Administered Orally Sales Market Share by Type (2017-2022)
Table 47. APAC Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)
Table 48. APAC Vaccines Administered Orally Sales Market Share by Application (2017-2022)
Table 49. Europe Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)
Table 50. Europe Vaccines Administered Orally Sales Market Share by Country (2017-2022)
Table 51. Europe Vaccines Administered Orally Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Vaccines Administered Orally Revenue Market Share by Country (2017-2022)
Table 53. Europe Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)
Table 54. Europe Vaccines Administered Orally Sales Market Share by Type (2017-2022)
Table 55. Europe Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)
Table 56. Europe Vaccines Administered Orally Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Vaccines Administered Orally Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Vaccines Administered Orally Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Vaccines Administered Orally Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Vaccines Administered Orally Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Vaccines Administered Orally Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Vaccines Administered Orally Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Vaccines Administered Orally
Table 66. Key Market Challenges & Risks of Vaccines Administered Orally
Table 67. Key Industry Trends of Vaccines Administered Orally
Table 68. Vaccines Administered Orally Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Vaccines Administered Orally Distributors List
Table 71. Vaccines Administered Orally Customer List
Table 72. Global Vaccines Administered Orally Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Vaccines Administered Orally Sales Market Forecast by Region
Table 74. Global Vaccines Administered Orally Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Vaccines Administered Orally Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Vaccines Administered Orally Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Vaccines Administered Orally Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Vaccines Administered Orally Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Vaccines Administered Orally Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Vaccines Administered Orally Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Vaccines Administered Orally Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Vaccines Administered Orally Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Vaccines Administered Orally Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Vaccines Administered Orally Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Vaccines Administered Orally Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Vaccines Administered Orally Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Vaccines Administered Orally Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Vaccines Administered Orally Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Vaccines Administered Orally Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Vaccines Administered Orally Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Vaccines Administered Orally Revenue Market Share Forecast by Application (2023-2028)
Table 92. Merck Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck Vaccines Administered Orally Product Offered
Table 94. Merck Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Merck Main Business
Table 96. Merck Latest Developments
Table 97. GSK Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 98. GSK Vaccines Administered Orally Product Offered
Table 99. GSK Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. GSK Main Business
Table 101. GSK Latest Developments
Table 102. Sanofi Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 103. Sanofi Vaccines Administered Orally Product Offered
Table 104. Sanofi Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Sanofi Main Business
Table 106. Sanofi Latest Developments
Table 107. Lanzhou Institute Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 108. Lanzhou Institute Vaccines Administered Orally Product Offered
Table 109. Lanzhou Institute Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Lanzhou Institute Main Business
Table 111. Lanzhou Institute Latest Developments
Table 112. Serum Institute Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 113. Serum Institute Vaccines Administered Orally Product Offered
Table 114. Serum Institute Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Serum Institute Main Business
Table 116. Serum Institute Latest Developments
Table 117. Valneva Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 118. Valneva Vaccines Administered Orally Product Offered
Table 119. Valneva Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Valneva Main Business
Table 121. Valneva Latest Developments
Table 122. Shanghai United Cell Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 123. Shanghai United Cell Vaccines Administered Orally Product Offered
Table 124. Shanghai United Cell Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Shanghai United Cell Main Business
Table 126. Shanghai United Cell Latest Developments
Table 127. Bibcol Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 128. Bibcol Vaccines Administered Orally Product Offered
Table 129. Bibcol Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Bibcol Main Business
Table 131. Bibcol Latest Developments
Table 132. PaxVax Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 133. PaxVax Vaccines Administered Orally Product Offered
Table 134. PaxVax Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. PaxVax Main Business
Table 136. PaxVax Latest Developments
Table 137. Vabiotech Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 138. Vabiotech Vaccines Administered Orally Product Offered
Table 139. Vabiotech Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Vabiotech Main Business
Table 141. Vabiotech Latest Developments
Table 142. Tiantan Biological Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 143. Tiantan Biological Vaccines Administered Orally Product Offered
Table 144. Tiantan Biological Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Tiantan Biological Main Business
Table 146. Tiantan Biological Latest Developments
Table 147. EuBiologics Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 148. EuBiologics Vaccines Administered Orally Product Offered
Table 149. EuBiologics Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. EuBiologics Main Business
Table 151. EuBiologics Latest Developments
Table 152. Panacea Biotec Ltd Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 153. Panacea Biotec Ltd Vaccines Administered Orally Product Offered
Table 154. Panacea Biotec Ltd Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Panacea Biotec Ltd Main Business
Table 156. Panacea Biotec Ltd Latest Developments
Table 157. Bio-Med Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 158. Bio-Med Vaccines Administered Orally Product Offered
Table 159. Bio-Med Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Bio-Med Main Business
Table 161. Bio-Med Latest Developments
Table 162. Halfkin Bio-Pharmaceuticals Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors
Table 163. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product Offered
Table 164. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Halfkin Bio-Pharmaceuticals Main Business
Table 166. Halfkin Bio-Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Vaccines Administered Orally
Figure 2. Vaccines Administered Orally Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaccines Administered Orally Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Vaccines Administered Orally Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Vaccines Administered Orally Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Human
Figure 10. Product Picture of Animal
Figure 11. Global Vaccines Administered Orally Sales Market Share by Type in 2021
Figure 12. Global Vaccines Administered Orally Revenue Market Share by Type (2017-2022)
Figure 13. Vaccines Administered Orally Consumed in Public
Figure 14. Global Vaccines Administered Orally Market: Public (2017-2022) & (K Units)
Figure 15. Vaccines Administered Orally Consumed in Private
Figure 16. Global Vaccines Administered Orally Market: Private (2017-2022) & (K Units)
Figure 17. Global Vaccines Administered Orally Sales Market Share by Application (2017-2022)
Figure 18. Global Vaccines Administered Orally Revenue Market Share by Application in 2021
Figure 19. Vaccines Administered Orally Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Vaccines Administered Orally Revenue Market Share by Company in 2021
Figure 21. Global Vaccines Administered Orally Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Vaccines Administered Orally Revenue Market Share by Geographic Region in 2021
Figure 23. Global Vaccines Administered Orally Sales Market Share by Region (2017-2022)
Figure 24. Global Vaccines Administered Orally Revenue Market Share by Country/Region in 2021
Figure 25. Americas Vaccines Administered Orally Sales 2017-2022 (K Units)
Figure 26. Americas Vaccines Administered Orally Revenue 2017-2022 ($ Millions)
Figure 27. APAC Vaccines Administered Orally Sales 2017-2022 (K Units)
Figure 28. APAC Vaccines Administered Orally Revenue 2017-2022 ($ Millions)
Figure 29. Europe Vaccines Administered Orally Sales 2017-2022 (K Units)
Figure 30. Europe Vaccines Administered Orally Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Vaccines Administered Orally Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Vaccines Administered Orally Revenue 2017-2022 ($ Millions)
Figure 33. Americas Vaccines Administered Orally Sales Market Share by Country in 2021
Figure 34. Americas Vaccines Administered Orally Revenue Market Share by Country in 2021
Figure 35. United States Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Vaccines Administered Orally Sales Market Share by Region in 2021
Figure 40. APAC Vaccines Administered Orally Revenue Market Share by Regions in 2021
Figure 41. China Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Vaccines Administered Orally Sales Market Share by Country in 2021
Figure 48. Europe Vaccines Administered Orally Revenue Market Share by Country in 2021
Figure 49. Germany Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Vaccines Administered Orally Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Vaccines Administered Orally Revenue Market Share by Country in 2021
Figure 56. Egypt Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Vaccines Administered Orally Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Vaccines Administered Orally in 2021
Figure 62. Manufacturing Process Analysis of Vaccines Administered Orally
Figure 63. Industry Chain Structure of Vaccines Administered Orally
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs